QLT Company Profile (NASDAQ:QLTI)

Analyst Ratings

Consensus Ratings for QLT (NASDAQ:QLTI) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.50 (153.42% upside)

Analysts' Ratings History for QLT (NASDAQ:QLTI)
Show:
DateFirmActionRatingPrice TargetActions
6/17/2016Royal Bank Of CanadaReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for QLT (NASDAQ:QLTI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/5/2016Q116($0.09)($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415($0.09)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q3($0.10)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q2($0.09)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115($0.06)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414$0.14$0.31ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q314($0.12)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214($0.12)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114($0.13)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2014Q413($0.14)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.11)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q213($0.10)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q113($0.14)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/21/2013Q412($0.22)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.22)($0.25)$9.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012($0.23)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012($0.20)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012($0.20)$0.04ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011($0.13)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.15)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for QLT (NASDAQ:QLTI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.08)($0.08)($0.08)
Q2 20161($0.09)($0.09)($0.09)
Q3 20161($0.11)($0.11)($0.11)
Q4 20161($0.12)($0.12)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for QLT (NASDAQ:QLTI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/18/2013special$3.926/28/20136/24/20136/27/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for QLT (NASDAQ:QLTI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/29/2015Jason AryehDirectorBuy18,400$2.50$46,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Axial Capital Master, L.P.Major ShareholderSell7,563,053$3.47$26,243,793.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Jason AryehDirectorBuy288,000$3.47$999,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014John W KozarichDirectorBuy10,000$3.59$35,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Jeffrey A MecklerDirectorBuy20,000$3.60$72,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2014Public Equity K/S NbMajor ShareholderSell1,000,000$5.80$5,800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Axial Capital Master, L.P.Major ShareholderSell288,890$4.39$1,268,227.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2013Jeffrey A MecklerDirectorBuy30,000$4.36$130,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Sukhi JagpalCFOSell10,000$7.95$79,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013John W KozarichDirectorBuy10,000$7.97$79,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2013Jeffrey A MecklerDirectorBuy20,000$7.96$159,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2012Alexander R LussowVPSell230,000$7.52$1,729,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2012Alexander R LussowVPSell5,000$7.72$38,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Alexander R LussowVPSell5,000$7.55$37,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Linda LupiniVPSell22,993$7.85$180,495.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for QLT (NASDAQ:QLTI)
DateHeadline
07/18/16 11:30 AMQlt Incorporated (NASDAQ:QLTI) Short Interest Increased By 7.97% - Consumer Eagle
07/09/16 05:23 PMBroker Outlook For QLT Inc. (NASDAQ:QLTI) - Fiscal Standard
07/01/16 08:47 AMHC Stocks Review: Transition Therapeutics Inc (USA) (NASDAQ:TTHI), QLT Inc. (USA) (NASDAQ:QLTI) - share market updates (press release)
06/30/16 08:52 AMStock Highlights: QLT Inc. (NASDAQ:QLTI), Netflix, Inc. (NASDAQ:NFLX), Nokia Corporation (ADR) (NYSE:NOK ... - KC Register
06/23/16 04:01 PMQLT INC/BC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security -
06/17/16 05:47 PMEarnings Estimates Spotlight: QLT Inc. (NASDAQ:QLTI) - News Oracle
06/17/16 05:47 PMHave a look at Price Moves: QLT Inc. (NASDAQ:QLTI) , EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) - Street Updates
06/17/16 03:19 PMQLT Announces Results of Annual General Meeting of Shareholders - [at noodls] - VANCOUVER, British Columbia, June 17, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ('QLT' or the 'Company') announces that, on a vote by ballot, the six incumbent directors of the Company ...
06/17/16 08:45 AMUS market rally given extra fuel by merger activity
06/16/16 11:23 PMAegerion, QLT Ink Merger Deal to Form Novelion Therapeutics -
06/16/16 06:15 PMWall Street holds on to gains ahead of Fed statement
06/16/16 10:12 AMUPDATE: U.S. stock futures gain ground with Yellen ahead
06/16/16 10:12 AMPre-Open Stock Movers 06/15: (AEGR) (PN) (EXAS) Higher; (LAKE) (SALT) (WFM) Lower (more...)
06/15/16 03:14 PM[video]Wall Street Loses Gains After Fed's Unsurprising June Call -
06/15/16 02:50 PMStocks Turn Lower After Yellen Expresses Confidence in U.S. Economy -
06/15/16 10:34 AMQLT (QLTI) Juimps on Aegerion Deal
06/15/16 10:05 AM6 Biopharma Movers Making a Run on Wednesday -
06/15/16 08:10 AM12 Stocks Moving In Wednesday's Pre-Market Session - Gainers Patriot National Inc (NYSE: PN) shares rose 30.06 percent to $9.00 in pre-market trading as Ebix Inc (NASDAQ: EBIX) offered to buy Patriot National for $9.50 per share. Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) shares rose 20.30 percent to $1.60 in pre-market trading following merger announcement with QLT. QLT Inc. (USA) (NASDAQ: QLTI) rose 18.18 percent to $1.69 in pre-market trading following merger announcement with Aegerion Pharmaceuticals. Carbylan Therapeutics Inc (NASDAQ: CBYL) rose 29.82 percent to $1.48 in pre-market trading following announcement of share purchase agreement. KalVista will become wholly-owned subsidary of Carbylan. EXACT Sciences Corporation (NASDAQ: EXAS) rose 17.25 percent to $11.01 in pre-market trading after surging 33.38 percent on ...Full story available on Benzinga.com
06/15/16 08:10 AMAegerion And QLT Agree To Merge - Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) and QLT Inc. (NASDAQ: QLTI) revealed that they reached a definitive merger agreement under which Aegerion will be merged with a fully owned indirect subsidiary of QLT. According to the company, after the planned merger completion, each outstanding share of Aegerion would be exchanged for 1.0256 shares of QLT common stock. The companies indicated QLT intends to change its name after the closing of the proposed transaction to Novelion Therapeutics Inc. and its shares would trade on the NASDAQ Global Select Market and the Toronto Stock Exchange. QLT ...Full story available on Benzinga.com
06/08/16 05:09 PMQLT, Inc. :QLTI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 -
06/02/16 09:03 AMBuy, Sell Or Hold Rating For QLT Inc. (NASDAQ:QLTI)? - Share Trading News - Buy, Sell Or Hold Rating For QLT Inc. (NASDAQ:QLTI)?Share Trading NewsThe stock's market capitalization is 79.51M, it has a 52-week low of 1.38 and a 52-week high of 4.40. The share price of the company (NASDAQ:QLTI) was up +4.51%, with a high of 1.51 during the day and the volume of QLT Inc. shares traded was 187991.
05/30/16 10:50 PMQLT Inc. (NASDAQ:QLTI) 1-Year High At $4.40 - Investor Newswire - QLT Inc. (NASDAQ:QLTI) 1-Year High At $4.40Investor NewswireYesterday, the stock of QLT Inc. (NASDAQ:QLTI) closed at $1.42 after opening at $1.41 and registering high of $1.50 and low of $1.40. The last price is $-2.91 away 1-year high of $4.40 and $0.11 away from low of $1.38 during same period. This study ...and more »
05/26/16 11:17 AMInsiders Are Gradually Buying QLT Inc. (NASDAQ:QLTI) - Wall Street Hints and News - Insiders Are Gradually Buying QLT Inc. (NASDAQ:QLTI)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at QLT Inc. (NASDAQ:QLTI) have increased their position in the stock by 7.78% over the past 6 months. Insiders now own 0.50% of total outstanding shares. There are both legal and illegal types of insider ...and more »
05/26/16 11:17 AMQLT Inc. (NASDAQ:QLTI) Closes At $1.43 - RealistInvestor.com - QLT Inc. (NASDAQ:QLTI) Closes At $1.43RealistInvestor.comThe technical analysis of QLT Inc. (NASDAQ:QLTI) stock highlights the stock is $-0.15 points away -9.76% from its 50-day MA of $1.55. It is $-0.85 or -37.76% away $2.25, the 200-day Moving Average (MA) of stock. Yesterday, the stock of QLT Inc.and more »
05/05/16 06:27 AMQLT Inc. reports 1Q loss -
05/05/16 06:11 AMQLT Announces First Quarter 2016 Results - [at noodls] - VANCOUVER, British Columbia, May 05, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ('QLT' or the 'Company') reported financial results today for the first quarter ended March 31, 2016. Unless ...
05/02/16 06:58 AMQLT Cancels $20 Million Private Placement -
05/02/16 06:20 AMQLT Terminates $20 Million Private Placement - [at noodls] - VANCOUVER, Canada, May 02, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ('QLT' or the 'Company') today announced that it has terminated the previously announced US$20 million private placement ...
05/02/16 06:06 AMQLT INC/BC Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial Statements and -
04/22/16 06:25 AMQLT Inc. Completes Enrollment in its Natural History Study - [at noodls] - VANCOUVER, British Columbia, April 22, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI); (TSX:QLT) ('QLT' or the 'Company') announced today completion of enrollment in its retrospective, uncontrolled, multicenter ...
04/11/16 05:02 AMQLT INC/BC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition o -
03/15/16 01:22 PMLatest Analysts Reports On QLT Inc. (NASDAQ:QLTI) - Risers & Fallers - Latest Analysts Reports On QLT Inc. (NASDAQ:QLTI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of QLT Inc. (NASDAQ:QLTI). The latest broker reports which have been released state 0 analysts have a rating of “buy”, 1 analysts “outperform”, 1 analysts “hold”, 0 analysts ...
02/05/16 03:23 PMQLT INC/BC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements -
02/05/16 12:35 PM1:35 pm QLT Inc acquires 7.2 mln common shares in Aralez Pharmaceuticals, which was formed through the combination of POZEN (POZN) and Tribute Pharmaceuticals, for $45 mln -
01/13/16 05:03 AMQLT INC/BC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statement -
12/28/15 07:26 AMQLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
12/11/15 01:23 PMQLT INC/BC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -
12/08/15 12:16 PMQLT INC/BC Financials -

Social

About QLT

QLT logoQLT Inc. is a biotechnology company. The Company is focused on the development and commercialization of ocular products. The Company's operations consist of clinical development programs focused on its synthetic retinoid, QLT091001, for the treatment of certain age-related and inherited retinal diseases (IRD) caused by retinal pigment epithelium protein 65 (RPE65) and lecithin: retinol acyltransferase (LRAT) gene mutations. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal. The Company is developing QLT091001 for the treatment of IRD caused by RPE65 and LRAT gene mutations, which indication includes Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP). It has completed a Phase Ib clinical proof of concept study and a follow-up retreatment study in LCA and RP patients with autosomal recessive mutations in RPE65 or LRAT, and a Phase 1b study in RP patients with autosomal dominant mutations in RPE65.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: QLTI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.38
  • 50 Day Moving Average: $1.41
  • 200 Day Moving Average: $1.85
  • P/E Ratio: N/A
  • P/E Growth: 0.18
  • Market Cap: $73.96M
  • Beta: 0.1
  • Current Year EPS Consensus Estimate: $-0.4000 EPS
  • Next Year EPS Consensus Estimate: $-0.4400 EPS
Additional Links:
QLT (NASDAQ:QLTI) Chart for Thursday, July, 28, 2016